Literature DB >> 24789918

Lysosomal stress in obese adipose tissue macrophages contributes to MITF-dependent Gpnmb induction.

Tanit L Gabriel1, Marc J Tol1, Roelof Ottenhof1, Cindy van Roomen1, Jan Aten2, Nike Claessen2, Berend Hooibrink3, Barbara de Weijer4, Mireille J Serlie4, Carmen Argmann5, Leonie van Elsenburg1, Johannes M F G Aerts1, Marco van Eijk6.   

Abstract

In obesity, adipose tissue (AT) contains crown-like structures where macrophages surround nonviable adipocytes. To understand how AT macrophages (ATMs) contribute to development of insulin resistance, we examined their character in more detail. In silico analysis of F2 mouse populations revealed significant correlation between adipose glycoprotein nonmetastatic melanoma protein B (Gpnmb) expression and body weight. In obese mice and obese individuals, Gpnmb expression was induced in ATMs. Cultured RAW264.7 cells were used to obtain insight into the mechanism of Gpnmb regulation. Gpnmb was potently induced by lysosomal stress inducers, including palmitate and chloroquine, or Torin1, an inhibitor of mammalian target of rapamycin complex 1 (mTORC1). These stimuli also provoked microphthalmia transcription factor (MITF) translocation to the nucleus, and knockdown of MITF by short hairpin RNA indicated its absolute requirement for Gpnmb induction. In agreement with our in vitro data, reduced mTORC1 activity was observed in isolated ATMs from obese mice, which coincided with increased nuclear MITF localization and Gpnmb transcription. Aberrant nutrient sensing provokes lysosomal stress, resulting in attenuated mTORC1 activity and enhanced MITF-dependent Gpnmb induction. Our data identify Gpnmb as a novel marker for obesity-induced ATM infiltration and potentiator of interleukin-4 responses and point toward a crucial role for MITF in driving part of the ATM phenotype.
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789918     DOI: 10.2337/db13-1720

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

Review 1.  A Next Generation Multiscale View of Inborn Errors of Metabolism.

Authors:  Carmen A Argmann; Sander M Houten; Jun Zhu; Eric E Schadt
Journal:  Cell Metab       Date:  2015-12-17       Impact factor: 27.287

2.  Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease.

Authors:  Vagishwari Murugesan; Jun Liu; Ruhua Yang; Haiquin Lin; Andrew Lischuk; Gregory Pastores; Xiaokui Zhang; Wei-Lien Chuang; Pramod K Mistry
Journal:  Blood Cells Mol Dis       Date:  2016-12-13       Impact factor: 3.039

Review 3.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

Review 4.  The Roles of Adipose Tissue Macrophages in Human Disease.

Authors:  Weizheng Liang; Yanxu Qi; Hongyang Yi; Chenyu Mao; Qingxue Meng; Hao Wang; Chunfu Zheng
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

5.  TFEB-GDF15 axis protects against obesity and insulin resistance as a lysosomal stress response.

Authors:  Jinyoung Kim; Seong Hun Kim; Hyereen Kang; Soyeon Lee; Shi-Young Park; Yoonil Cho; Yu-Mi Lim; Ji Woong Ahn; Young-Hwan Kim; Seungsoo Chung; Cheol Soo Choi; Yeon Jin Jang; Hye Soon Park; Yoonseok Heo; Kook Hwan Kim; Myung-Shik Lee
Journal:  Nat Metab       Date:  2021-03-22

6.  Identification of novel adipokines in the joint. Differential expression in healthy and osteoarthritis tissues.

Authors:  Javier Conde; Morena Scotece; Vanessa Abella; Rodolfo Gómez; Verónica López; Rosa Villar; Miguel Hermida; Jesús Pino; Juan Jesús Gómez-Reino; Oreste Gualillo
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

7.  Induction of Sphk1 activity in obese adipose tissue macrophages promotes survival.

Authors:  Tanit L Gabriel; Mina Mirzaian; Berend Hooibrink; Roelof Ottenhoff; Cindy van Roomen; Johannes M F G Aerts; Marco van Eijk
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

8.  Transcriptome of HPβCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics.

Authors:  Jorge L Rodriguez-Gil; Laura L Baxter; Dawn E Watkins-Chow; Nicholas L Johnson; Cristin D Davidson; Steven R Carlson; Arturo A Incao; Kerri L Wallom; Nicole Y Farhat; Frances M Platt; Ryan K Dale; Forbes D Porter; William J Pavan
Journal:  Hum Mol Genet       Date:  2021-11-30       Impact factor: 5.121

9.  Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease.

Authors:  André R A Marques; Tanit L Gabriel; Jan Aten; Cindy P A A van Roomen; Roelof Ottenhoff; Nike Claessen; Pilar Alfonso; Pilar Irún; Pilar Giraldo; Johannes M F G Aerts; Marco van Eijk
Journal:  PLoS One       Date:  2016-01-15       Impact factor: 3.240

10.  Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis.

Authors:  Akihiro Katayama; Atsuko Nakatsuka; Jun Eguchi; Kazutoshi Murakami; Sanae Teshigawara; Motoko Kanzaki; Tomokazu Nunoue; Kazuyuki Hida; Nozomu Wada; Tetsuya Yasunaka; Fusao Ikeda; Akinobu Takaki; Kazuhide Yamamoto; Hiroshi Kiyonari; Hirofumi Makino; Jun Wada
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.